Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France

References

• Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81
   PubMed Web of Science ®Google Scholar
• Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 2004;350:2239-46
   PubMed Web of Science ®Google Scholar
• Postma R, Schröder FH. Screening for prostate cancer. Eur J Cancer 2005;41:825-33
   PubMed Web of Science ®Google Scholar
• Welch HG, Fisher ES, Gottlieb DJ, et al. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst 2007;99:1395-400
   PubMedGoogle Scholar
• Fowler JE, Jr Bigler SA, Miles D, et al. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol 2000;163:813-8
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Aus G, Bolla M, et al. EAU Guidelines on prostate cancer. Eur Urol 2008;53:68-80
   PubMed Web of Science ®Google Scholar
• Djavan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 2000;163:1144-8
   PubMed Web of Science ®Google Scholar
• Nam RK, Saskin R, Lee Y, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010;183:963-8
   PubMed Web of Science ®Google Scholar
• Nickel JC, Furuta A, Chancellor MB, et al. Best of the AUA Annual Meeting. highlights from the 2010 American Urological Association Meeting, May 29-June 3, 2010, San Francisco, CA. Rev Urol 2010;12:e134–46
   Google Scholar
• Roberts RO, Bergstralh EJ, Besse JA, et al. Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997. Urology 2002;59:79-84
   PubMed Web of Science ®Google Scholar
• Seitz C, Palermo S, Djavan B. Prostate biopsy. Minerva Urol Nefrol 2003;55:205-18
   PubMedGoogle Scholar
• Autorino R, De Sio M, Di Lorenzo G, et al. How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature. J Urol 2005;174:209-17
   Web of Science ®Google Scholar
• Haese A, de la Taille A, Van Poppel H, et al. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol 2008;54:1081-8
   PubMed Web of Science ®Google Scholar
• Marks LS, Fradet Y, Deras IL, et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 2007;69:532-5
   PubMed Web of Science ®Google Scholar
• Deras IL, Aubin SM, Blase A, et al. PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 2008;179:1587-92
   PubMed Web of Science ®Google Scholar
• de la Taille A, Irani J, Graefen M, et al. Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions. J Urol 2011;185:2119-25
   PubMed Web of Science ®Google Scholar
• Aubin SMJ, Reid J, Sarno MJ, et al. PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial. J Urol 2010;184:1947-52
   PubMed Web of Science ®Google Scholar
• Tombal B, Ameye F, de la Taille A, et al. Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion. World J Urol 2012;30:251-6
   PubMed Web of Science ®Google Scholar
• Van Poppel H, Haese A, Graefen M, et al. The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance. BJU Int 2012;109:360-6
   PubMed Web of Science ®Google Scholar
• Rébillard X, Malavaud B, Rischmann P. Étude scientifique sur le dépistage individuel et le traitement précoce du cancer de la prostate en France. Marché 2007-OPEPES-01. Paris: Association Française d’Urologie. http://www.atoute.org/n/article118.html. Accessed November 2011
   Google Scholar
• Fujita K, Landis P, McNeil BK, et al. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol 2009;182:2664-9
   PubMed Web of Science ®Google Scholar
• Simsir A, Kismali E, Mammadov R, et al. Is it possible to predict sepsis, the most serious complication in prostate biopsy? Urol Int 2010;84:395-9
   PubMed Web of Science ®Google Scholar
• Grover SA, Zowall H, Coupal L, et al. Prostate cancer: 12. The economic burden. CMAJ 1999;160:685-90
   PubMed Web of Science ®Google Scholar
• Sun P, Seftel A, Swindle R, et al. The costs of caring for erectile dysfunction in a managed care setting: evidence from a large national claims database. J Urol 2005;174:1948-52
   PubMed Web of Science ®Google Scholar
• Edbrooke DL, Hibbert CL, Kingsley JM, et al. The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit. Crit Care Med 1999;27:1760-7
   PubMed Web of Science ®Google Scholar
• US PCA3 Budget Impact Study. Data on hand at Hologic/Gen-Probe
   Google Scholar
• Nakanishi H, Groskopf J, Fritsche HA, et al. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. J Urol 2008;179:1804-9
   PubMed Web of Science ®Google Scholar
• Ploussard G, Durand X, Xylinas E, et al. Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance. Eur Urol 2011;59:422-9
   PubMed Web of Science ®Google Scholar
• Auprich M, Chun FKH, Ward JF, et al. Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging. Eur Urol 2011;59:96-105
   PubMed Web of Science ®Google Scholar
• Tombal B, Andriole GL, Smets L, et al. PCA3 can reduce repeat prostate biopsies with maintained sensitivity of detecting high-grade cancer: application of an expert recommendations model to the placebo cohort of the REDUCE study. 27th Annual European Association of Urology (EAU) Congress, Milan, 2012; Abs. 262. www.uroweb.org/events/abstracts-online/?AID=36287. Accessed March 2012
   Google Scholar